VIR Activist 13D/13G Filings - Vir Biotechnology Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	Filing
2021-02-12 5:00 pm Purchase	13G	VIR BIOTECHNOLOGY INC VIR	SCANGOS GEORGE A	7,001,308 5.5%	52,329 (+0.75%)	View
2021-02-11 06:02 am Purchase	13G	VIR BIOTECHNOLOGY INC VIR	Temasek Holdings (Private) Ltd	5,499,999 4.3%	5,499,999 (New Position)	View
2020-07-29 3:50 pm Unchanged	13D	VIR BIOTECHNOLOGY INC VIR	ARCH Venture Fund IX L.P.	28,666,663 23%	0 (Unchanged)	View
2020-05-07 07:04 am Unchanged	13G	VIR BIOTECHNOLOGY INC VIR	Alaska Permanent Fund Corp	5,555,556 5.06%	0 (Unchanged)	View
2020-05-04 4:18 pm Purchase	13G	VIR BIOTECHNOLOGY INC VIR	GSK plc GSK	6,626,027 6.03%	6,626,027 (New Position)	View
2020-02-14 4:55 pm Purchase	13G	VIR BIOTECHNOLOGY INC VIR	SOFTBANK VISION FUND (AIV M1) L.P.	22,616,666 20.6%	22,616,666 (New Position)	View
2020-02-14 4:06 pm Purchase	13G	VIR BIOTECHNOLOGY INC VIR	SCANGOS GEORGE A	6,948,979 6.3%	6,948,979 (New Position)	View
2019-12-05 3:02 pm Purchase	13G	VIR BIOTECHNOLOGY INC VIR	Alaska Permanent Fund Corp	5,555,556 5.1%	5,555,556 (New Position)	View
2019-11-08 1:49 pm Purchase	13D	VIR BIOTECHNOLOGY INC VIR	ARCH Venture Fund IX L.P.	28,666,663 26.2%	28,666,663 (New Position)	View
2019-10-25 4:31 pm Unchanged	13G	VIR BIOTECHNOLOGY INC VIR	Temasek Holdings (Private) Ltd	0 0%	0 (Unchanged)	View

Goto Prev, 0, 1